๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Clear Renal Cell Carcinoma

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Darlifarnib, Cabozantinib, Adagrasib GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors NCT04977453Phase 1, Phase 213 sites๐Ÿ“ New York๐Ÿ“ New York๐Ÿ“ Huntersville GI Innovation, Inc. ยท Tests: GI-101, Pembrolizumab (KEYTRUDAยฎ), Lenvatinib, GI-101A An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07469683Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: SLC-3010 + Axitinib, Axitinib Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors NCT04777994Phase 130 sites๐Ÿ“ Tucson๐Ÿ“ New Haven๐Ÿ“ Baltimore Calico Life Sciences LLC ยท Tests: ABBV-CLS-484, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI), Programmed Cell Deatโ€ฆ Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer NCT07128680Phase 12 sites๐Ÿ“ Duarte๐Ÿ“ Irvine City of Hope Medical Center ยท Tests: Biospecimen Collection, Bone Scan, Computed Tomography, Faecalibacterium prausnitzii-containing Bacterial Strain Formulโ€ฆ Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors NCT05856981Phase 17 sites๐Ÿ“ Detroit๐Ÿ“ St Louis๐Ÿ“ Canton Sairopa B.V. ยท Tests: ADU-1805, Pembrolizumab Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma NCT07011719Phase 3183 sites๐Ÿ“ Gilbert๐Ÿ“ Goodyear๐Ÿ“ Phoenix Arcus Biosciences, Inc. ยท Tests: Casdatifan, Cabozantinib, Placebo Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) NCT05665361Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Sasanlimab, Palbocicilib Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer NCT07227415Phase 1, Phase 2183 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Fayetteville Pfizer ยท Tests: PF-08634404, Ipilimumab, Axitinib, Casdatifan Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC NCT06863311Phase 25 sites๐Ÿ“ La Jolla๐Ÿ“ Indianapolis๐Ÿ“ St Louis Karie Runcie ยท Tests: XL092, Nivolumab A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NCT06805825Phase 15 sites๐Ÿ“ Ann Arbor๐Ÿ“ Cleveland๐Ÿ“ Portland Novelty Nobility, Inc. ยท Tests: NN3201 Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma NCT07564232Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Cyclophosphamide, Fludarabine, LNK001 Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site๐Ÿ“ San Francisco Rahul Aggarwal ยท Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma NCT07300241Phase 114 sites๐Ÿ“ Duarte๐Ÿ“ San Diego๐Ÿ“ New Haven Neomorph, Inc ยท Tests: NEO-811 A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma NCT06699602Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Cemiplimab, Fianlimab Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer NCT07383441Phase 341 sites๐Ÿ“ Fayetteville๐Ÿ“ Jonesboro๐Ÿ“ Rogers SWOG Cancer Research Network ยท Tests: Axitinib, Biospecimen Collection, Bone Scan, Cabozantinib, Clostridium butyricum CBM 588 Probiotic Strain Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial NCT06866262Phase 1, Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Inulin, Ipilimumab A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body NCT06413680Phase 1, Phase 211 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ North Haven Regeneron Pharmaceuticals ยท Tests: REGN10597, Cemiplimab Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors NCT05706129Phase 1, Phase 210 sites๐Ÿ“ Melbourne๐Ÿ“ Sydney๐Ÿ“ Clermont-Ferrand Lumara Bio Oncologics GmbH ยท Tests: [68Ga]Ga-DPI-4452, [177Lu]Lu-DPI-4452 Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01) NCT07770802Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Hangzhou Huasai Biomedicine Co., Ltd. ยท Tests: Cyclophosphamid, Fludarabine, Interleukin 2 subcutaneous injection, HS-IT101 monotherapy Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis NCT06794229Phase 24 sites๐Ÿ“ St Louis๐Ÿ“ Philadelphia๐Ÿ“ Dallas Qian Qin ยท Tests: Zanzalintinib, Nivolumab A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer NCT06380816Phase 1, Phase 24 sites๐Ÿ“ London๐Ÿ“ Manchester๐Ÿ“ Newcastle upon Tyne Cancer Research UK ยท Tests: UCB4594 Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors NCT05176483Phase 1122 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Palo Alto Exelixis ยท Tests: Zanzalintinib, Nivolumab, Ipilimumab, Nivolumab + Relatlimab, Prednisone A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) NCT07195682Phase 111 sites๐Ÿ“ Boston๐Ÿ“ New York๐Ÿ“ Philadelphia Bristol-Myers Squibb ยท Tests: BMS-986506, Pumitamig, Ipilimumab A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma NCT07123090Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Boston Stephanie Berg ยท Tests: Sasanlimab, Palbociclib, Axitinib Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma NCT07097935Phase 1, Phase 21 site๐Ÿ“ Beijing Jiangsu Hansoh Pharmaceutical Co., Ltd. ยท Tests: HS-10516 + Lenvatinib Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma NCT06053658Phase 26 sites๐Ÿ“ Irvine๐Ÿ“ Boston๐Ÿ“ Boston M.D. Anderson Cancer Center ยท Tests: Tivozanib, Nivolumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy